Corporate Profile

• A Message from Management
• Corporate Data
• Board of Directors
• Philosophy and Declaration of Corporate Conduct
• History
• Facilities
• Group Companies

Our Business

• Self-Medication
• Prescription Pharmaceutical
• Overseas Development

Social and Environment Activities

• Compliance
• Environmental Measures
• Support for Research in Life Sciences
• Information Disclosure
• Simulation of Interest in Self-Medication
• Contribution to Cultural Activities

News Releases

• News Releases

Oct 1, 2019	Taisho and Moberg Pharma sign exclusive license agreement for the development and commercialization of MOB-015 in Japan
Jul 2, 2019	Taisho Completed Procedures for the Acquisition of UPSA SAS(Taisho Pharmaceutical Holdings)
Feb 28, 2019	Notice Regarding the Tender Offer for Shares of Duoc Hau Giang Pharmaceutical JSC(Taisho Pharmaceutical Holdings)
Dec 19, 2018	Taisho Agreed To Acquire UPSA SAS, A French Pharmaceutical Manufacturer, and its Business Assets, Owned by Bristol-Myers Squibb Company(Taisho Pharmaceutical Holdings)

more